Camurus Ab Stock Performance
| CAMRF Stock | USD 55.00 3.00 5.17% |
The firm shows a Beta (market volatility) of 0.96, which signifies possible diversification benefits within a given portfolio. Camurus AB returns are very sensitive to returns on the market. As the market goes up or down, Camurus AB is expected to follow. At this point, Camurus AB has a negative expected return of -0.21%. Please make sure to confirm Camurus AB's total risk alpha, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Camurus AB performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Camurus AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2026. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Quick Ratio | 2.65 | |
| Fifty Two Week Low | 7.48 | |
| Fifty Two Week High | 21.81 |
Camurus |
Camurus AB Relative Risk vs. Return Landscape
If you would invest 6,422 in Camurus AB on December 2, 2025 and sell it today you would lose (922.00) from holding Camurus AB or give up 14.36% of portfolio value over 90 days. Camurus AB is currently producing negative expected returns and takes up 2.8267% volatility of returns over 90 trading days. Put another way, 25% of traded otc stocks are less volatile than Camurus, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Camurus AB Target Price Odds to finish over Current Price
The tendency of Camurus OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 55.00 | 90 days | 55.00 | close to 99 |
Based on a normal probability distribution, the odds of Camurus AB to move above the current price in 90 days from now is close to 99 (This Camurus AB probability density function shows the probability of Camurus OTC Stock to fall within a particular range of prices over 90 days) .
Camurus AB Price Density |
| Price |
Predictive Modules for Camurus AB
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Camurus AB. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Camurus AB Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Camurus AB is not an exception. The market had few large corrections towards the Camurus AB's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Camurus AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Camurus AB within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.28 | |
β | Beta against Dow Jones | 0.96 | |
σ | Overall volatility | 4.80 | |
Ir | Information ratio | -0.1 |
Camurus AB Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Camurus AB for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Camurus AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Camurus AB generated a negative expected return over the last 90 days | |
| The company reported the revenue of 4.5 M. Net Loss for the year was (23.45 M) with profit before overhead, payroll, taxes, and interest of 515.22 M. | |
| Camurus AB has accumulated about 22.42 M in cash with (24.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58. | |
| Roughly 53.0% of the company shares are held by company insiders |
Camurus AB Fundamentals Growth
Camurus OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Camurus AB, and Camurus AB fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Camurus OTC Stock performance.
| Return On Equity | -1.49 | |||
| Return On Asset | -0.83 | |||
| Profit Margin | (1.62) % | |||
| Current Valuation | 1.2 B | |||
| Shares Outstanding | 38.38 M | |||
| Price To Book | 11.42 X | |||
| Price To Sales | 80.89 X | |||
| Revenue | 4.5 M | |||
| EBITDA | (29 M) | |||
| Cash And Equivalents | 22.42 M | |||
| Cash Per Share | 0.58 X | |||
| Debt To Equity | 0.03 % | |||
| Book Value Per Share | 1.12 X | |||
| Cash Flow From Operations | (24.54 M) | |||
| Earnings Per Share | (0.63) X | |||
About Camurus AB Performance
By analyzing Camurus AB's fundamental ratios, stakeholders can gain valuable insights into Camurus AB's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Camurus AB has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Camurus AB has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Camurus AB , a pharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, Japan, and internationally. Camurus AB was founded in 1991 and is headquartered in Lund, Sweden. Camurus Ab is traded on OTC Exchange in the United States.Things to note about Camurus AB performance evaluation
Checking the ongoing alerts about Camurus AB for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Camurus AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Camurus AB generated a negative expected return over the last 90 days | |
| The company reported the revenue of 4.5 M. Net Loss for the year was (23.45 M) with profit before overhead, payroll, taxes, and interest of 515.22 M. | |
| Camurus AB has accumulated about 22.42 M in cash with (24.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58. | |
| Roughly 53.0% of the company shares are held by company insiders |
- Analyzing Camurus AB's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Camurus AB's stock is overvalued or undervalued compared to its peers.
- Examining Camurus AB's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Camurus AB's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Camurus AB's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Camurus AB's otc stock. These opinions can provide insight into Camurus AB's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Camurus OTC Stock analysis
When running Camurus AB's price analysis, check to measure Camurus AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Camurus AB is operating at the current time. Most of Camurus AB's value examination focuses on studying past and present price action to predict the probability of Camurus AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Camurus AB's price. Additionally, you may evaluate how the addition of Camurus AB to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Transaction History View history of all your transactions and understand their impact on performance |